MCKINNEY, Texas (December 18, 2017)—Home infusion stakeholders have been urging lawmakers to include the Medicare Home Infusion Therapy Access Act of 2017 (S 1738) or Section 101 of Medicare Part B Improvement Act of 2017 (HR 3178) in any end-of-year legislative package to ensure Medicare beneficiaries can continue to receive life-sustaining infusion therapies in their homes.

New tool introduced to reconcile information sent in by state Medicaid rates with Medicare rates.

—Via AAHomecare, WASHINGTON, D.C. (December 14, 2017)—CMS recently provided an update on a State Operational Technical Advisory (SOTA) call regarding CURES Medicaid provisions. AAHomecare was one of nearly 300 participants on the call, which was put together for the benefit of Medicaid program officials, but also included industry stakeholders.

Third-party sellers endanger patient safety.

—Via AAHomecare, WASHINGTON, D.C. (December 14, 2017)—AAHomecare has learned that third party sellers in North Dakota (and possibly other states) have been advertising and selling through Amazon.com CPAP devices without a prescription or any other medical supervision. Such sales are likely in violation of state and federal laws, as well as Amazon’s own restrictions on the sale of prescription devices.